| 1 |
Díaz-Sánchez E, López-Salas A, Mirchandani-Duque M, Alvarez-Contino JE, Sánchez-Pérez JA, Fuxe K, Borroto-Escuela DO, García-Casares N, Narváez M. Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion. Biomed Pharmacother 2023;161:114433. [PMID: 36848750 DOI: 10.1016/j.biopha.2023.114433] [Reference Citation Analysis]
|
| 2 |
Requena-Ocaña N, Araos P, Serrano-Castro PJ, Flores-López M, García-Marchena N, Oliver-Martos B, Ruiz JJ, Gavito A, Pavón FJ, Serrano A, Mayoral F, Suarez J, Fonseca FR. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder. Int J Mol Sci 2023;24. [PMID: 36674698 DOI: 10.3390/ijms24021183] [Reference Citation Analysis]
|
| 3 |
Perrottelli A, Sansone N, Giordano GM, Caporusso E, Giuliani L, Melillo A, Pezzella P, Bucci P, Mucci A, Galderisi S. Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature. J Pers Med 2022;12. [PMID: 36556290 DOI: 10.3390/jpm12122070] [Reference Citation Analysis]
|
| 4 |
Gallant M, Mercier K, Rioux-perreault C, Lemaire-paquette S, Piché A. Prevalence of persistent symptoms at least 1 month after SARS-CoV-2 Omicron infection in adults. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2022. [DOI: 10.3138/jammi-2022-0026] [Reference Citation Analysis]
|
| 5 |
Saikarthik J, Saraswathi I, Alarifi A, Al-Atram AA, Mickeymaray S, Paramasivam A, Shaikh S, Jeraud M, Alothaim AS. Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome-A narrative review. PeerJ 2022;10:e14227. [PMID: 36353605 DOI: 10.7717/peerj.14227] [Reference Citation Analysis]
|
| 6 |
Kay CD, Costa AS, Vannorsdall TD, Aduen P, Vila-castelar C, Burstein SM, Pollak L, Leibel DK, Sherman JC, Bungenberg J, Reetz K, Quiroz YT. Neuropsychological Outcomes of COVID-19: A Multicenter, Cross-Cultural Study of Patients Referred for Outpatient Assessment. COVID 2022;2:1253-1264. [DOI: 10.3390/covid2090092] [Reference Citation Analysis]
|
| 7 |
Mena-vázquez N, Ortiz-márquez F, Cabezudo-garcía P, Padilla-leiva C, Diaz-cordovés Rego G, Muñoz-becerra L, Ramírez-garcía T, Lisbona-montañez JM, Manrique-arija S, Mucientes A, Núñez-cuadros E, Galindo Zavala R, Serrano-castro PJ, Fernández-nebro A. Longitudinal Study of Cognitive Functioning in Adults with Juvenile Idiopathic Arthritis. Biomedicines 2022;10:1729. [DOI: 10.3390/biomedicines10071729] [Reference Citation Analysis]
|
| 8 |
Bohmwald K, Andrade CA, Mora VP, Muñoz JT, Ramírez R, Rojas MF, Kalergis AM. Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System. Int J Mol Sci 2022;23:5817. [PMID: 35628626 DOI: 10.3390/ijms23105817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Preobrazhenskaya IS. COVID-associated cognitive impairments: A review. Consilium Medicum 2022;24:96-102. [DOI: 10.26442/20751753.2022.2.201512] [Reference Citation Analysis]
|
